News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AmpliPhi Biosciences (TGEN) Announces First Closing of $2.7 Million


11/17/2011 7:02:19 AM

RICHMOND, Va. & SEATTLE, Wa. & COLWORTH, UK--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (APHB.PK), the leader in the development of bacteriophage-based anti-bacterial therapies to treat drug resistant infections, has announced that is has closed on an initial amount of $2.7M in equity investment and convertible loan notes to support the further progress of the Company. In total, the Company is seeking up to $5m in this round.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES